Elanco Animal Health Incorporated (ELAN) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Elanco Animal Health Incorporated (ELAN) closed at USD 22.55 on 2026-10-14, a change of +1.9 % over the past year, with a market capitalization of USD 11.76B.

Elanco Animal Health Incorporated recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Elanco Animal Health Incorporated key figures

Previous close

USD 22.55 (2026-10-14)

1-year change

+1.9 %

Market cap

USD 11.76B

Enterprise value

USD 15.46B

P/E ratio (trailing)

-54.74

P/E ratio (forward)

18.32

EPS (trailing)

-0.43

EPS (forward)

1.28

PEG ratio

4.04

Price to book

1.78

Revenue growth

10.2 %

Earnings growth

440.5 %

Dividend per share (trailing)

0.00

Short ratio

6.69

Employees

9,400

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Elanco Animal Health Incorporated

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Elanco Animal Health Incorporated and compare it with other stocks.